Last reviewed · How we verify

NCT07154849

Comparative Study Between the Efficacy of Intravenous Hydrocortisone and Intravenous Dexmedetomidine for Prevention of Postoperative Shivering After General Anaesthesia for Abdominal Surgeries

Recruiting now Phase 4 Last updated 4 September 2025
What this trial tests

Phase 4 trial testing Hydrocortisone in Shivering in 70 participants. Currently enrolling.

Timeline
11 November 2024
Primary endpoint
1 November 2025
20 December 2025

Quick facts

Lead sponsorAin Shams University
PhasePhase 4
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment70
Start date11 November 2024
Primary completion1 November 2025
Estimated completion20 December 2025
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams University

Who can join

Adults 18 to 65, any sex, with Shivering. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim and purpose of this study is to compare the efficacy of intravenous hydrocortisone and intravenous dexmedetomidine for prevention and treatment of postoperative shivering after general anesthesia for abdominal surgeries.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Hydrocortisone

Trials testing the same drug.

Other recruiting trials for Shivering

Currently open trials in the same condition.

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07154849.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing